While real-world results may be slightly less, the improvements go beyond weight: Lower blood sugar, blood pressure, and triglycerides Reduced waist circumference and sleep apnea symptoms Better health-related quality of life Fewer major cardiovascular events Reduced progression of fatty liver disease and chronic kidney diseaseeven in the absence of weight loss (Mozaffarian et al., 2025)
The total depends on the medication you qualify for, the subscription tier, and whether the drug is an FDA-approved brand product or a compounded formulation
Hong F, Jaruga B, Kim WH, Radaeva S, El-Assal ON, Tian Z et al
Image Credits : AI Generated DOI : 10.1038/s41467-026-76175-2 Keywords : Clonorchis sinensis, clonorchiasis, liver fibrosis, CD8 TRM cells, tissue-resident memory T cells, chemokines, circulating biomarkers, chronic infection, cholangiocarcinoma, liver immunology Tags: bile duct injury in clonorchiasisblood-based biomarkers for liver diseaseCD8 tissue-resident memory T cellschemokine signaling in liver diseasecholangiocarcinoma risk factorsChronic Clonorchis sinensis infectionimmune cell interactions in chronic parasitic infectionsimmune pathways in parasitic infectionsliver fibrosis biomarkersliver inflammation and fibrosis mechanismslong-term effects of liver fluke infectionparasite-induced immune modulation
